NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Pharma, medtech & health distribution  /  Bio-Techne Corporation

Bio-Techne Corporation

bio-techne.com ↗
70
Latest disclosed NPS
2 May 2017
1
NPS entries
1 with a number
2017
Years covered
1 entries in all

NPS disclosures (1)

Search the database →

2 May 2017
NPS70

I mean there's a lot of tactics, but the overall, I think is Novus, Novus brand, the breadth, the better website, the better access, we follow customer metrics, we follow NPS, our NPS metrics have been going up continually, we have in R&D Systems well over 70% NPS, which is your Net Promoter Score.

— Charles R. Kummeth, Chief Executive Officer, Bio-Techne Corporation · Earnings call, Q3 2017 · 2 May 2017 · NI-D8E249D
Earnings call, Q3 2017 ↗

Retention disclosures (0)

Open in the retention database →

No retention figures yet.

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.